The dingo has been a bit sad lately (haven't we all, unless you are new to the register the past couple of months), but I wouldn't be attacking him for this one. Not sure about anyone else here that is genuine in their support of IMU, but I assign Her-Vaxx almost zero when considering the value of the company. I think we can still be bullish about IMU without kidding ourselves that given it's current de-prioritisation it would be a very surprising event that they managed to get any decent value for it. The company has clearly moved on to Azer and the CF33 programs and as an investor so should we (though I still hold a passing interest in B-cell generally and maybe Neo-POLEM could be something).
Just for the sake of chatting, I've loved the idea behind onCARlytics the moment I saw it and has been the primary reason i've kept plunging funds into what has been a rather dire situation from looking at the chart alone. Very excited to see some early data and it will be make or break as far as i'm concerned as to if IMU is something truly special or just another company with some decent potential for small specific indications, but not a paradigm shifting cancer breakthrough.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)